These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28761678)

  • 1. Polymer-free sirolimus-eluting stents in a large-scale all-comers population.
    Krackhardt F; Kočka V; Waliszewski MW; Utech A; Lustermann M; Hudec M; Studenčan M; Schwefer M; Yu J; Jeong MH; Ahn T; Wan Ahmad WA; Boxberger M; Schneider A; Leschke M
    Open Heart; 2017; 4(2):e000592. PubMed ID: 28761678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nine-month clinical outcomes in patients with diabetes treated with polymer-free sirolimus-eluting stents and 6‑month vs. 12‑month dual-antiplatelet therapy (DAPT).
    Krackhardt F; Waliszewski M; Rischner J; Piot C; Pansieri M; Ruiz-Poveda FL; Boxberger M; Noutsias M; Ríos XF; Kherad B
    Herz; 2019 Aug; 44(5):433-439. PubMed ID: 29356832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propensity score matched all comers population treated with ultra-thin strut bare metal and sirolimus-probucol coated drug-eluting stents of identical stent architecture.
    Krackhardt F; Rosli MA; Leschke M; Schneider A; Sperling C; Heang TM; Pons M; Sousa PJ; Kherad B; Waliszewski M
    Catheter Cardiovasc Interv; 2018 Jun; 91(7):1221-1228. PubMed ID: 28944613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-Hospital and 1-Year Clinical Results from the French Registry Using Polymer-Free Sirolimus-Eluting Stents in Acute Coronary Syndrome and Stable Coronary Artery Disease.
    Landolff Q; Quillot M; Picard F; Henry P; Sideris G; Bizeau O; Piot C; Jouve B; Rischner J; Mejri M; Charmasson C; Lasserre R; Pouliquen H; Joseph T; Monsegu J; Karsenty B; Martin Yuste V; Richet N; Lapeyre G; Beverelli F; Beygui F; Koning R
    J Interv Cardiol; 2023; 2023():8907315. PubMed ID: 38125031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients.
    Roguin A; Kandzari DE; Marcusohn E; Koolen JJ; Doros G; Massaro JM; Garcia-Garcia HM; Bennett J; Gharib EG; Cutlip DE; Waksman R
    Circ Cardiovasc Interv; 2018 Oct; 11(10):e007331. PubMed ID: 30354631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Coronary Stent Architecture on Clinical Outcomes: Do Minor Changes in Stent Architecture Really Matter?
    Nuruddin AAB; Ahmad WAW; Waliszewski M; Heang TM; Bang LH; Yusof AKM; Abidin IZ; Zuhdi AS; Krackhardt F
    Cardiol Ther; 2021 Jun; 10(1):175-187. PubMed ID: 33275200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 9-month results of polymer-free sirolimus eluting stents in young patients compared to a septuagenarian and octogenarian all-comer population.
    Kherad B; Waliszewski M; Leschke M; Kader MA; Bang LH; Ruiz-Poveda FL; Pieske B; Krackhardt F
    J Interv Cardiol; 2018 Jun; 31(3):338-344. PubMed ID: 29205492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymer-free sirolimus-eluting stent use in Europe and Asia: Ethnic differences in demographics and clinical outcomes.
    Krackhardt F; Waliszewski M; Wan Ahmad WA; Kočka V; Toušek P; Janek B; Trenčan M; Krajči P; Lozano F; Garcia-San Roman K; Otaegui Irurueta I; Garcia Del Blanco B; Wachowiak L; Vilalta Del Olmo V; Fernandez Nofrerías E; Ho Jeong M; Jung BC; Han KR; Piot C; Sebagh L; Rischner J; Pansieri M; Leschke M; Ahn TH
    PLoS One; 2020; 15(1):e0226606. PubMed ID: 31929543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A more-Comers populAtion trEated with an ultrathin struts polimer-free Sirolimus stent: an Italian post-maRketing study (the CAESAR registry).
    Tarantini G; Cardaioli F; De Iaco G; Tuccillo B; De Angelis MC; Mauro C; Boccalatte M; Trivisonno A; Ribichini F; Vadalà G; Caramanno G; Caruso M; Lombardi M; Fischetti D; Danesi A; Abbracciavento L; Lorenzoni G; Gregori D; Panza A; Nai Fovino L; Esposito G
    Front Cardiovasc Med; 2023; 10():1326091. PubMed ID: 38299080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of polymer-free biolimus-eluting stents versus ultrathin stents in unprotected left main or coronary bifurcation: A propensity score analysis from the RAIN and CHANCE registries.
    D'Ascenzo F; Gaido L; Bernardi A; Saglietto A; Franzé A; Ielasi A; Trabattoni D; Di Biasi M; Infantino V; Rognoni A; Helft G; Gangor A; Latini RA; De Luca L; Mitomo S; Ugo F; Smolka G; Huczek Z; Cortese B; Capodanno D; Chieffo A; Piazza F; di Mario C; Poli A; D'Urbano M; Romeo F; Giammaria M; Varbella F; Sheiban I; Escaned J; De Ferrari GM
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):522-529. PubMed ID: 31385427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes following polymer-free sirolimus-eluting stent implantations in unselected patients: A descriptive subgroup analysis in patients with renal impairment.
    Krackhardt F; Waliszewski MW; Kherad B; Barth C; Marcelli D
    Medicine (Baltimore); 2020 Jul; 99(29):e21244. PubMed ID: 32702903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized All-Comers Evaluation of a Permanent Polymer Zotarolimus-Eluting Stent Versus a Polymer-Free Amphilimus-Eluting Stent.
    Rozemeijer R; Stein M; Voskuil M; van den Bor R; Frambach P; Pereira B; Koudstaal S; Leenders GE; Timmers L; Rittersma SZ; Kraaijeveld AO; Agostoni P; Roes KC; Doevendans PA; Stella PR;
    Circulation; 2019 Jan; 139(1):67-77. PubMed ID: 30586704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Clinical Outcomes Following Single versus Multivessel Percutaneous Coronary Intervention Using Biodegradable Polymer Coated Sirolimus-Eluting Stent in an All-comers Patient Population.
    Chandwani P; Verma P; Saxena S; Ramachandran PK; Abhyankar A; Sandhu MS; Parikh N; Bhupali A; Jain S; Prajapati J
    Cardiovasc Hematol Agents Med Chem; 2016; 14(1):39-48. PubMed ID: 26585397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 48-Month Clinical Outcomes and Prognostic Factors in an All-Comers Population with Acute Coronary Syndrome and Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention with a Sirolimus-Eluting Stent.
    Tyczynski M; Kern A; Buller P; Gil RJ; Bil J
    J Pers Med; 2023 Nov; 13(11):. PubMed ID: 38003888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
    Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of an ultrathin strut biodegradable polymer-coated sirolimus-eluting stent: 12 months' results from the S-FLEX UK registry.
    Choudhury A; Garg S; Smith J; Sharp A; Nabais de Araujo S; Chauhan A; Patel N; Wrigley B; Chattopadhyay S; Zaman AG
    BMJ Open; 2019 Oct; 9(10):e026578. PubMed ID: 31604782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thin strut bare metal stents in patients with atrial fibrillation: Is there still a need for BMS?
    Leschke M; Waliszewski M; Pons M; Champin S; Nait Saidi L; Mok Heang T; Maskon O; Azman Bin Wan Ahmad W; Herberger D; Moulichon ME; Rischner J; Robin C; Leclercq F; Peyre JP; Faurie B; Schneider A
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):358-66. PubMed ID: 26650913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative preclinical evaluation of a polymer-free sirolimus-eluting stent in porcine coronary arteries.
    Sperling C; Waliszewski MW; Kherad B; Krackhardt F
    Ther Adv Cardiovasc Dis; 2019; 13():1753944719826335. PubMed ID: 30803407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization: 3-Year Outcomes From the Randomized BIOFLOW V Trial.
    Kandzari DE; Koolen JJ; Doros G; Garcia-Garcia HM; Bennett J; Roguin A; Gharib EG; Cutlip DE; Waksman R;
    JACC Cardiovasc Interv; 2020 Jun; 13(11):1343-1353. PubMed ID: 32499026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial.
    Iglesias JF; Heg D; Roffi M; Tüller D; Noble S; Muller O; Moarof I; Cook S; Weilenmann D; Kaiser C; Cuculi F; Häner J; Jüni P; Windecker S; Pilgrim T
    Circ Cardiovasc Interv; 2019 Aug; 12(8):e008024. PubMed ID: 31525083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.